Five-year favorable outcome of patients with early rheumatoid arthritis in the 2000s: Data from the ESPOIR cohort

Journal of Rheumatology

Volumn 40, Issue 10, 2013, Pages 1650-1657

  Combe, Bernard ^d   Rincheval, Nathalie ^d   Benessiano, Joelle ^a   Berenbaum, Francis ^b   Cantagrel, Alain ^c   Daurès, Jean Pierre ^d   Dougados, Maxime ^e   Fardellone, Patrice ^f   Fautrel, Bruno ^g   Flipo, Rene M ^h   Goupille, Philippe ⁱ   Guillemin, Francis ^j   Le Loët, Xavier ^k   Logeart, Isabelle ^l   Mariette, Xavier ^m   Meyer, Olivier ^a   Ravaud, Philippe ⁿ   Saraux, Alain ^o   Schaeverbeke, Thierry ^p   Sibilia, Jean ^q  

^a BICHAT HOSPITAL   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c TOULOUSE UNIVERSITY HOSPITAL   (France)

^d LAPEYRONIE HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f AMIENS UNIVERSITY HOSPITAL   (France)

^g PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^h LILLE UNIVERSITY HOSPITAL   (France)

ⁱ UNIVERSITÉ DE TOURS   (France)

^j UNIVERSITY HOSPITAL OF NANCY   (France)

^k UNIVERSITY OF ROUEN   (France)

^l MSD Paris   (France)

^m UNIVERSITÉ PARIS SACLAY   (France)

ⁿ INSERM   (France)

^o BREST UNIVERSITY HOSPITAL   (France)

^p BORDEAUX UNIVERSITY HOSPITAL   (France)

^q UNIVERSITY HOSPITAL OF STRASBOURG   (France)

more..

Author keywords

Early arthritis; ESPOIR cohort; Outcome; Rheumatoid arthritis; Treatment; Undifferentiated arthritis

Indexed keywords

ABATACEPT; ADALIMUMAB; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TOCILIZUMAB; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ARTICLE; BONE RADIOGRAPHY; COHORT ANALYSIS; COMORBIDITY; DAS28; DISEASE ACTIVITY; DISEASE CLASSIFICATION; DISEASE DURATION; DISEASE PREDISPOSITION; FEMALE; FOLLOW UP; FOOT DISEASE; HAND DISEASE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SURGERY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT REFERRAL; PRESCRIPTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RHEUMATOID ARTHRITIS;

EARLY ARTHRITIS; ESPOIR COHORT; OUTCOME; RHEUMATOID ARTHRITIS; TREATMENT; UNDIFFERENTIATED ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; BIOLOGICAL PRODUCTS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84885157509     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.121515     Document Type: Article

References (44)

1. Roux CH, Saraux A, Le Bihan E, Fardellone P, Guggenbuhl P, Fautrel B, et al. Rheumatoid arthritis and spondyloarthropathies: Geographical variations in prevalence in France. J Rheumatol 2007;34:117-22.
2. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984;27:864-72.
3. Dellhag B, Bjelle A. A five-year followup of hand function and activities of daily living in rheumatoid arthritis patients. Arthritis Care Res 1999;12:33-41.
4. Wolfe F, Hawley DJ. The longterm outcomes of rheumatoid arthritis: Work disability: a prospective 18 year study of 823 patients. J Rheumatol 1998;25:2108-17.
5. Barrett EM, Scott DG, Wiles NJ, Symmons DP. The impact of rheumatoid arthritis on employment status in the early years of disease: A UK community-based study. Rheumatology 2000;39:1403-9.
6. Jantti J, Aho K, Kaarela K, Kautiainen H. Work disability in an inception cohort of patients with seropositive rheumatoid arthritis: A 20 year study. Rheumatology 1999;38:1138-41.
7. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum 1994;37:481-94.
8. Lard LR, Visser H, Speyer I, vander Horst-Bruinsma IE, Zwinderman AH, Breedveld FC, et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: Comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51.
9. Bukhari MA, Wiles NJ, Lunt M, Harrison BJ, Scott DG, Symmons DP, et al. Influence of disease modifying therapy on radiographic outcome in inflammatory polyarthritis at 5 years: Results from a large observational inception study. Arthritis Rheum 2003;48:46-53.
10. Nell VP, Machold KP, Eberl G, Stamm TA, Uffmann M, Smolen JS. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 2004;43:906-14.
11. Finckh A, Liang MH, van Herckenrode CM, de Pablo P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum 2006;55:864-72.
12. Lukas C, Combe B, Ravaud P, Sibilia J, Landewe R, van der Heijde D. Favorable effect of very early disease-modifying antirheumatic drug treatment on radiographic progression in early inflammatory arthritis: Data from the Étude et Suivi des polyarthrites indifférenciées récentes (study and followup of early undifferentiated polyarthritis). Arthritis Rheum 2011;63:1804-11.
13. Grigor C, Capell H, Stirling A, McMahon AD, Lock P, Vallance R, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): A single-blind randomised controlled trial. Lancet 2004;364:263-9.
14. Schipper LG, Kievit W, den Broeder AA, van der Laar MA, Adang EM, Fransen J, et al. Treatment strategies aiming at remission in early rheumatoid arthritis patients: Starting with methotrexate monotherapy is cost-effective. Rheumatology 2011;50:1320-30.
15. Landewe RB, Boers M, Verhoeven AC, Westhovens R, van de Laar MA, Markusse HM, et al. COBRA combination therapy in patients with early rheumatoid arthritis: Long-term structural benefits of a brief intervention. Arthritis Rheum 2002;46:347-56.
16. Smolen JS, Aletaha D, Bijlsma JW, Breedveld FC, Boumpas D, Burmester G, et al; T2T Expert Committee. Treating rheumatoid arthritis to target: Recommendations of an international task force. Ann Rheum Dis 2010;69:631-7.
17. Emery P, Breedveld FC, Hall S, Durez P, Chang DJ, Robertson D, et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): A randomised, double-blind, parallel treatment trial. Lancet 2008;372:375-82.
18. St. Clair EW, van der Heijde DM, Smolen JS, Maini RN, Bathon JM, Emery P, et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: A randomized, controlled trial. Arthritis Rheum 2004;50:3432-43.
19. Breedveld F, Kavanaugh AF, Cohen SB, Pavelka K, van Vollenhoven R, Perez JL, et al. Early treatment of rheumatoid arthritis with adalimumab plus methotrexate vs adalimumab alone or methotrexate alone: The PREMIER study. Arthritis Rheum 2006;54:26-37.
20. Smolen JS, Aletaha D, Koeller M, Weisman MH, Emery P. New therapies for treatment of rheumatoid arthritis. Lancet 2007;370:1861-74.
21. Combe B, Landewe R, Lukas C, Bolosiu H, Breedveld F, Dougados M, et al. EULAR evidence recommendations for the management of early arthritis. Report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2007;66:34-45.
22. Smolen JS, Landewé R, Breedveld FC, Dougados M, Emery P, Gaujoux-Viala C, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis 2010;69:964-75.
23. Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012;64:625-39.
24. Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daures JP, Dougados M, et al. The ESPOIR cohort: A ten-year follow-up of early arthritis in France. Methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 2007;74:440-5.
25. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
26. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, et al. 2010 rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
27. Guillemin F, Coste J, Pouchot J, Gezail M, Bregeon C, Sany J, et al. The AIMS2-SF: A short form of the Arthritis Impact Measurement Scales 2. Arthritis Rheum 1997;40:1267-74.
28. van der Heijde DM, van Leeuwen MA, van Riel PL, Koster AM, van't Hof MA, van Rijswijk MS, et al. Biannual radiographic assessments of hands and feet in a three-year prospective followup of patients with early rheumatoid arthritis. Arthritis Rheum 1992;35:26-34.
29. Fautrel B, Combe B, Rincheval N, Dougados M; ESPOIR Scientific Committee. Level of agreement of the 1987 ACR and 2010 ACR/EULAR rheumatoid arthritis classification criteria: An analysis based on ESPOIR cohort data. Ann Rheum Dis 2012;71:386-9.
30. Symmons DP, Silman AJ. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register. Arthritis Res Ther 2006;8:214.
31. Combe B, Dougados M, Goupille P, Cantagrel A, Eliaou JF, Sibilia J, et al. Prognostic factors for radiographic damage in early rheumatoid arthritis. A multiparameter prospective study. Arthritis Rheum 2001;44:1736-43.
32. Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52:2616-24.
33. de Vries-Bouwstra JK, Goekoop-Ruiterman YP, Verpoort KN, Schreuder GM, Ewals JA, Terwiel JP, et al. Progression of joint damage in early rheumatoid arthritis: Association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies. Arthritis Rheum 2008;58:1293-8.
34. Verstappen SM, Lunt M, Bunn DK, Scott DG, Symmons DP. In patients with early inflammatory polyarthritis, ACPA positivity, younger age and inefficacy of the first non-biological DMARD are predictors for receiving biological therapy: Results from the Norfolk Arthritis Register. Ann Rheum Dis 2011;70:1428-32.
35. Funovits J, Aletaha D, Bykerk V, Combe B, Dougados M, Emery P, et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Methodological report phase I. Ann Rheum Dis 2010;69:1589-95.
36. Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, et al. Early referral to the rheumatologist for early arthritis patients: Evidence for suboptimal care. Results from the ESPOIR cohort. Rheumatology 2010;49:147-55.
37. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009-19.
38. Finckh A, Choi HK, Wolfe F. Progression of radiographic joint damage in different eras: Trends towards milder disease in rheumatoid arthritis are attributable to improved treatment. Ann Rheum Dis 2006;65:1192-7.
39. Uhlig T, Heiberg T, Mowinckel P, Kvien TK. Rheumatoid arthritis is milder in the new millennium: Health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis 2008;67:1710-5.
40. Camacho EM, Verstappen SM, Lunt M, Bunn DK, Symmons DP. Influence of age and sex on functional outcome over time in a cohort of patients with recent-onset inflammatory polyarthritis: Results from the Norfolk Arthritis Register. Arthritis Care Res 2011;63:1745-52.
41. Michaud K, Wallenstein G, Wolfe F. Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: A longitudinal study of 18, 485 patients. Arthritis Care Res 2011;63:366-72.
42. Bukhari M, Lunt M, Barton A, Bunn D, Silman A, Symmons D. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann Rheum Dis 2007;66:389-93.
43. van der Helm-van Mil AH, le Cessie S, van Dongen H, Breedveld FC, Toes RE, Huizinga TW. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: How to guide individual treatment decisions. Arthritis Rheum 2007;56:433-40.
44. Gottenberg JE, Dayer JM, Lukas C, Ducot B, Chiocchia G, Cantagrel A, et al. Serum IL-6 and IL-21 are associated with markers of B cell activation and structural progression in early rheumatoid arthritis: Results from the ESPOIR cohort. Ann Rheum Dis 2012;71:1243-8.